Recap: Health Catalyst Q4 Earnings
Shares of Health Catalyst (NASDAQ:HCAT) decreased in after-market trading after the company reported Q4 results.
Quarterly Results
Earnings per share increased 23.81% year over year to ($0.16), which beat the estimate of ($0.19).
Revenue of $53,279,000 higher by 22.48% year over year, which beat the estimate of $52,120,000.
Outlook
Earnings guidance hasn't been issued by the company for now.
Q1 revenue expected to be between $53,000,000 and $56,000,000.
Conference Call Details
Date: Feb 25, 2021
Time: 05:00 PM
ET Webcast URL: https://edge.media-server.com/mmc/p/hqjrxviv
Technicals
Company's 52-week high was at $55.07
Company's 52-week low was at $17.48
Price action over last quarter: Up 31.34%
Company Description
Health Catalyst Inc is engaged in providing data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, which is the key revenue driver, includes data platform, analytics applications and support services. This generates revenues primarily from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; and Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
See more from Benzinga
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
